Court Won't Block Generic Zyprexa In Canada
The court, following its usual practice, gave no reason for denying the appeal. A representative for Eli Lilly could not immediately be reached for comment.
Novopharm began selling Novo-Olanzapine, its version of Zyprexa, last year after winning a patent infringement case brought...
To view the full article, register now.